References
- Fornander T., Rutqvist L. E., Cedermark B. Adjuvant tamoxifen in early breast cancer occurrence of new primary cancers. Lancet 1989; 1: 117–19
- Vihko R., Alanko A., Isomaa V., Kauppila A. The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer. Med Oncol Tumor Pharmacother 1986; 3: 197–210
- Rajaniemi H., Kauppila A., Rönnberg L. LH(hCG) receptor in benign and malignant tumors of human ovary. Acta Obstet Gynecol Scand 1981; 101(SUPPL)83–6
- Kauppila A. Estrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature. Acta Oncol 1989; 28: 561–6
- Emons G., Brack C., Strum R., Ball P. GnRH-binding-sites in human epithelial ovarian carcinoma. Eur J Cancer Clin Oncol 1986; 22: 745–51
- Kauppila A., Bangah M., Burger H., Martikainen H. GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol 1992; 6: 271–4
- Healy D. L., Burger H. G., Mamers P. Inhibin as a marker for granulosa-cell tumors. N Engl J Med 1993; 329: 1539–42
- Mählck C.-G. Plasma steroid hormones in women with epithelial ovarian carcinoma. Actu Obstet Cynecol Scand 1986; Suppl 137: 1–31